Juncture Wealth Strategies’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$548K Sell
4,340
-199
-4% -$26.2K 0.14% 107
2026
Q1
$633K Hold
4,539
0.21% 68
2025
Q4
$557K Sell
4,539
-19
-0.4% -$2.31K 0.18% 70
2025
Q3
$506K Sell
4,558
-3,199
-41% -$364K 0.17% 71
2025
Q2
$860K Sell
7,757
-763
-9% -$81.2K 0.31% 52
2025
Q1
$955K Sell
8,520
-36
-0.4% -$3.71K 0.37% 45
2024
Q4
$790K Buy
8,556
+31
+0.4% +$2.79K 0.29% 54
2024
Q3
$715K Buy
8,525
+1,433
+20% +$109K 0.28% 55
2024
Q2
$487K Buy
7,092
+2,705
+62% +$181K 0.2% 66
2024
Q1
$321K Buy
+4,387
New +$337K 0.14% 84
2019
Q2
Sell
-3,148
Closed -$205K 110
2019
Q1
$205K Buy
+3,148
New +$209K 0.16% 114

Other funds holding GILD

Juncture Wealth Strategies's GILD Position: Q2 2026 in Review

Juncture Wealth Strategies reduced its Gilead Sciences (GILD) stake by 4.4% in Q2 2026, selling an estimated $26.2K and leaving 4,340 shares worth $548K. The position accounts for 0.14% of the portfolio, ranked #107.

Juncture Wealth Strategies first reported a position in GILD in Q1 2019 and has held it in 11 quarters since. The position peaked at $955K in Q1 2025. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Juncture Wealth Strategies held 4,340 shares of Gilead Sciences worth $548K as of Q2 2026.
  • Juncture Wealth Strategies sold 199 Gilead Sciences shares in Q2 2026, an estimated $26.2K.
  • Gilead Sciences made up 0.14% of Juncture Wealth Strategies's portfolio in Q2 2026, its #107 holding.
  • Juncture Wealth Strategies first reported a position in Gilead Sciences in Q1 2019 and has held it in 11 quarters since.
  • Juncture Wealth Strategies's Gilead Sciences position peaked at $955K in Q1 2025.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Juncture Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.